person · Reporting owner

Hilado Maria Teresa

Disclosed activity across 5 companies

Tapewire entity: 33120
SEC CIK: 0001587868

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Allergan plcAGN · Entity 149298	Executive Vice President	April 03, 2018	April 05, 2018
CAMPBELL'S CoCPB · Entity 3700	Director	September 25, 2026	September 28, 2026
FULLER H B COFUL · Entity 4255	Director	July 01, 2021	July 02, 2021
ZIMMER BIOMET HOLDINGS, INC.ZBH · Entity 3278	Director	September 30, 2026	October 03, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Allergan plc

Report date April 03, 2018 · Filed April 05, 2018

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Ordinary Shares, par value $0.0001SEC Table I · non-derivative	Direct	25,911	Reported balance After 2018-04-03 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2018-04-03 · Tax withholding · Disposed 619 · Balance 25,911 F1: Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.

Filing footnotes · ownership attribution and instrument terms

F1: Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.

CAMPBELL'S Co

Report date September 25, 2026 · Filed September 28, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Phantom StockSEC Table II · derivative / convertible security	Direct	45,050.93	Reported balance After 2026-09-25 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2026-09-25 · Grant · Acquired 2,332.86 · Balance 45,050.93 F1: Each share of Phantom Stock is the economic equivalent of one share of issuer common stock. F2: Phantom shares are fully vested. F3: The value of Phantom Stock is payable in cash from the Company's Supplemental Retirement Plan upon reporting person's retirement, resignation or termination. F4: Includes 731.99 shares acquired through dividend reinvestment since the reporting person's last report.

Filing footnotes · ownership attribution and instrument terms

F1: Each share of Phantom Stock is the economic equivalent of one share of issuer common stock.

F2: Phantom shares are fully vested.

F3: The value of Phantom Stock is payable in cash from the Company's Supplemental Retirement Plan upon reporting person's retirement, resignation or termination.

F4: Includes 731.99 shares acquired through dividend reinvestment since the reporting person's last report.

FULLER H B CO

Report date July 01, 2021 · Filed July 02, 2021

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	30,167.16	Reported balance After 2021-07-01 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2021-07-01 · Grant · Acquired 2,090.43 · Balance 30,167.16 F1: These units convert into shares of common stock on a 1-for-1 basis. F2: These units will be converted into shares of common stock upon retirement, death, disability or certain specified events, all as defined in such plan, subject to holding periods required by law. F3: This amount includes stock units acquired pursuant to a dividend equivalent feature of the Directors Deferred Compensation Plan.
Common StockSEC Table I · non-derivative	Direct	1,345.5	Reported balance Holding disclosure · report date 2021-07-01 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 1,345.5

Filing footnotes · ownership attribution and instrument terms

F1: These units convert into shares of common stock on a 1-for-1 basis.

F2: These units will be converted into shares of common stock upon retirement, death, disability or certain specified events, all as defined in such plan, subject to holding periods required by law.

F3: This amount includes stock units acquired pursuant to a dividend equivalent feature of the Directors Deferred Compensation Plan.

ZIMMER BIOMET HOLDINGS, INC.

Report date September 30, 2026 · Filed October 03, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Phantom Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $89.85	Direct	13,392.107	Reported balance After 2026-09-30 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2026-09-30 · Grant · Acquired 375.626 · Balance 13,392.107 F1: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4: Includes 32.614 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Filing footnotes · ownership attribution and instrument terms

F1: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4: Includes 32.614 phantom stock units accrued on July 31, 2026 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

PPD, Inc.

Report date December 08, 2021 · Filed December 08, 2021

Section 16 reporting ended · disclosed 2021-12-08. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2021-12-08 transaction · row 1 1 source row Row 1 · 2021-12-08 · Disposition to issuer · Disposed 39,363 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). F2: Includes 2,164 shares of common stock subject to a restricted stock unit grant (the "RSUs") which provided for vesting on the earlier of the one-year anniversary of the grant date and the date of the next regularly scheduled annual meeting of stockholders of the Issuer. At the effective time of the Merger, the RSUs were canceled and converted into the right to receive an amount of cash equal to the Merger Consideration (as defined below) multiplied by the number of restricted stock units being so canceled and converted. F3: At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash (the "Merger Consideration").

Filing footnotes · ownership attribution and instrument terms

F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger").

F2: Includes 2,164 shares of common stock subject to a restricted stock unit grant (the "RSUs") which provided for vesting on the earlier of the one-year anniversary of the grant date and the date of the next regularly scheduled annual meeting of stockholders of the Issuer. At the effective time of the Merger, the RSUs were canceled and converted into the right to receive an amount of cash equal to the Merger Consideration (as defined below) multiplied by the number of restricted stock units being so canceled and converted.

F3: At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash (the "Merger Consideration").

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
December 08, 2021 Filed Dec 8, 2021 21:38 UTC	PPD, Inc. PPD · Entity 15247	Disposition to issuerCommon Stock	39,363	$47.50	$1,869,742.50	Disclosure SEC source: 0001437749-21-028107 · rdgdoc.xml · nonDerivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). F2 · shares: Includes 2,164 shares of common stock subject to a restricted stock unit grant (the "RSUs") which provided for vesting on the earlier of the one-year anniversary of the grant date and the date of the next regularly scheduled annual meeting of stockholders of the Issuer. At the effective time of the Merger, the RSUs were canceled and converted into the right to receive an amount of cash equal to the Merger Consideration (as defined below) multiplied by the number of restricted stock units being so canceled and converted. F2 · price: Includes 2,164 shares of common stock subject to a restricted stock unit grant (the "RSUs") which provided for vesting on the earlier of the one-year anniversary of the grant date and the date of the next regularly scheduled annual meeting of stockholders of the Issuer. At the effective time of the Merger, the RSUs were canceled and converted into the right to receive an amount of cash equal to the Merger Consideration (as defined below) multiplied by the number of restricted stock units being so canceled and converted. F3 · price: At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash (the "Merger Consideration"). Read SEC document
September 30, 2021 Filed Oct 4, 2021 21:17 UTC	ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278	GrantPhantom Stock Units · Derivative	185.347	$0.00 Strike: $148.37	$0.00	Disclosure SEC source: 0001062993-21-009205 · form4.xml · derivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,115.008 Underlying: Common Stock · 185.347 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: 92.674 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: 92.674 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 5.503 phantom stock units accrued on July 31, 2021 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document
September 29, 2021 Filed Oct 1, 2021 21:11 UTC	CAMPBELL'S Co CPB · Entity 3700	GrantPhantom Stock · Derivative	1,364.64	$0.00	$0.00	Disclosure SEC source: 0000016732-21-000115 · wf-form4_163312265908573.xml · derivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,252.95 Underlying: Common Stock · 1,364.64 shares Expires not disclosed F1 · derivative.exercise_price: Each share of Phantom Stock is the economic equivalent of one share of issuer common stock. F2 · derivative.exercise_date: Phantom shares are fully vested. F3 · derivative.expiration_date: The value of phantom stock is payable in cash from the Company's Supplemental Retirement Plan upon reporting person's retirement, resignation or termination. F4 · balance_after: Includes 100.70 shares acquired through dividend reinvestment since the reporting person's last report. Read SEC document
July 01, 2021 Filed Jul 2, 2021 16:54 UTC	FULLER H B CO FUL · Entity 4255	GrantStock Units · Derivative	2,090.43	$64.58 Strike: $0.00	$134,999.97	Disclosure SEC source: 0001225208-21-010051 · doc4.xml · derivative · entry 2 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,167.16 Underlying: Common Stock · 2,090.43 shares Expires not disclosed F1 · derivative.exercise_price: These units convert into shares of common stock on a 1-for-1 basis. F2 · derivative.exercise_date: These units will be converted into shares of common stock upon retirement, death, disability or certain specified events, all as defined in such plan, subject to holding periods required by law. F2 · derivative.expiration_date: These units will be converted into shares of common stock upon retirement, death, disability or certain specified events, all as defined in such plan, subject to holding periods required by law. F3 · balance_after: This amount includes stock units acquired pursuant to a dividend equivalent feature of the Directors Deferred Compensation Plan. Read SEC document
June 30, 2021 Filed Jul 2, 2021 20:40 UTC	ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278	GrantPhantom Stock Units · Derivative	170.882	$0.00 Strike: $160.93	$0.00	Disclosure SEC source: 0001062993-21-006282 · form4.xml · derivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,924.158 Underlying: Common Stock · 170.882 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: 85.441 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: 85.441 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. Read SEC document
June 29, 2021 Filed Jul 1, 2021 20:55 UTC	CAMPBELL'S Co CPB · Entity 3700	GrantPhantom Stock · Derivative	1,281.5	$0.00	$0.00	Disclosure SEC source: 0000016732-21-000083 · wf-form4_162517289703506.xml · derivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,787.61 Underlying: Common Stock · 1,281.5 shares Expires not disclosed F1 · derivative.exercise_price: Each share of Phantom Stock is the economic equivalent of one share of issuer common stock. F2 · derivative.exercise_date: Phantom shares are fully vested. F3 · derivative.expiration_date: The value of phantom stock is payable in cash from the Company's Supplemental Retirement Plan upon reporting person's retirement, resignation or termination. F4 · balance_after: Includes 79.71 shares acquired through dividend reinvestment since the reporting person's last report. Read SEC document
May 14, 2021 Filed May 18, 2021 23:05 UTC	ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278	GrantRestricted Stock Units · Derivative	779.05	$0.00	$0.00	Disclosure SEC source: 0001062993-21-004826 · form4.xml · derivative · entry 2 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,934.401 Underlying: Common Stock · 779.05 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document
May 14, 2021 Filed May 18, 2021 23:05 UTC	ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278	GrantPhantom Stock Units · Derivative	500	$0.00 Strike: $166.87	$0.00	Disclosure SEC source: 0001062993-21-004826 · form4.xml · derivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,753.276 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 4.169 phantom stock units accrued on April 30, 2021 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document
April 23, 2021 Filed Apr 27, 2021 20:14 UTC	PPD, Inc. PPD · Entity 15247	GrantCommon Stock	2,164	$0.00	$0.00	Disclosure SEC source: 0001628280-21-007734 · wf-form4_161955442531079.xml · nonDerivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,363 F1 · kind: Represents a grant of restricted stock units which will vest on the earlier of the one-year anniversary of the grant date and the date of the next regularly scheduled annual meeting of stockholders of the issuer, subject to continued service through the vesting date. Read SEC document
March 31, 2021 Filed Apr 2, 2021 16:43 UTC	ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278	GrantPhantom Stock Units · Derivative	169.785	$0.00 Strike: $161.97	$0.00	Disclosure SEC source: 0001062993-21-003337 · form4.xml · derivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,249.107 Underlying: Common Stock · 169.785 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: 84.893 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: 84.893 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 4.502 phantom stock units accrued on January 29, 2021 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document
March 30, 2021 Filed Apr 1, 2021 13:21 UTC	CAMPBELL'S Co CPB · Entity 3700	GrantPhantom Stock · Derivative	1,201.46	$0.00	$0.00	Disclosure SEC source: 0000016732-21-000046 · wf-form4_161728325942639.xml · derivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,489.78 Underlying: Common Stock · 1,201.46 shares Expires not disclosed F1 · derivative.exercise_price: Each share of Phantom Stock is the economic equivalent of one share of issuer common stock. F2 · derivative.exercise_date: Phantom shares are fully vested. F3 · derivative.expiration_date: The value of phantom stock is payable in cash from the Company's Supplemental Retirement Plan upon reporting person's retirement, resignation or termination. F4 · balance_after: Includes 71.01 shares acquired through dividend reinvestment since the reporting person's last report. Read SEC document
December 31, 2020 Filed Jan 5, 2021 21:54 UTC	ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278	GrantPhantom Stock Units · Derivative	179.891	$0.00 Strike: $152.87	$0.00	Disclosure SEC source: 0001062993-21-000115 · form4.xml · derivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,074.82 Underlying: Common Stock · 179.891 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: 89.946 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: 89.946 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 5.237 phantom stock units accrued on October 30, 2020 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document
December 30, 2020 Filed Jan 4, 2021 21:34 UTC	CAMPBELL'S Co CPB · Entity 3700	GrantPhantom Stock · Derivative	1,246.49	$0.00	$0.00	Disclosure SEC source: 0000016732-21-000010 · wf-form4_160979603757605.xml · derivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,217.31 Underlying: Common Stock · 1,246.49 shares Expires not disclosed F1 · derivative.exercise_price: Each share of Phantom Stock is the economic equivalent of one share of issuer common stock. F2 · derivative.exercise_date: Phantom shares are fully vested. F3 · derivative.expiration_date: The value of phantom stock is payable in cash from the Company's Supplemental Retirement Plan upon reporting person's retirement, resignation or termination. F4 · balance_after: Includes 58.08 shares acquired through dividend reinvestment since the reporting person's last report. Read SEC document
September 30, 2020 Filed Oct 2, 2020 20:38 UTC	ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278	GrantPhantom Stock Units · Derivative	202.563	$0.00 Strike: $135.76	$0.00	Disclosure SEC source: 0001062993-20-004779 · form4.xml · derivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,889.692 Underlying: Common Stock · 202.563 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: 101.282 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: 101.282 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 4.34 phantom stock units accrued on July 31, 2020 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document
September 29, 2020 Filed Oct 1, 2020 20:43 UTC	CAMPBELL'S Co CPB · Entity 3700	GrantPhantom Stock · Derivative	1,246.49	$0.00	$0.00	Disclosure SEC source: 0000016732-20-000121 · wf-form4_160158499200399.xml · derivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,912.74 Underlying: Common Stock · 1,246.49 shares Expires not disclosed F1 · derivative.exercise_price: Each share of Phantom Stock is the economic equivalent of one share of issuer common stock. F2 · derivative.exercise_date: Phantom shares are fully vested. F3 · derivative.expiration_date: The value of phantom stock is payable in cash from the Company's Supplemental Retirement Plan upon reporting person's retirement, resignation or termination. F4 · balance_after: Includes 46.6079 shares acquired through dividend reinvestment since the reporting person's last report. Read SEC document
July 08, 2020 Filed Jul 9, 2020 18:08 UTC	FULLER H B CO FUL · Entity 4255	GrantStock Units · Derivative	2,654.05	$43.33 Strike: $0.00	$114,999.99	Disclosure SEC source: 0001225208-20-009684 · doc4.xml · derivative · entry 2 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,736.21 Underlying: Common Stock · 2,654.05 shares Expires not disclosed F1 · derivative.exercise_price: These units convert into shares of common stock on a 1-for-1 basis. F2 · derivative.exercise_date: These units will be converted into shares of common stock upon retirement, death, disability or certain specified events, all as defined in such plan, subject to holding periods required by law. F2 · derivative.expiration_date: These units will be converted into shares of common stock upon retirement, death, disability or certain specified events, all as defined in such plan, subject to holding periods required by law. F3 · balance_after: This amount includes stock units acquired pursuant to a dividend equivalent feature of the Directors Deferred Compensation Plan. Read SEC document
June 30, 2020 Filed Jul 2, 2020 17:51 UTC	CAMPBELL'S Co CPB · Entity 3700	GrantPhantom Stock · Derivative	1,215.3553	$0.00	$0.00	Disclosure SEC source: 0000016732-20-000090 · wf-form4_159371230174242.xml · derivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,619.65 Underlying: Common Stock · 1,215.3553 shares Expires not disclosed F1 · derivative.exercise_price: Each share of Phantom Stock is the economic equivalent of one share of issuer common stock. F2 · derivative.exercise_date: Phantom shares are fully vested. F3 · derivative.expiration_date: The value of phantom stock is payable in cash from the Company's Supplemental Retirement Plan upon reporting person's retirement, resignation or termination. F4 · balance_after: Includes 36.66 shares acquired through dividend reinvestment since the reporting person's last report. Read SEC document
June 30, 2020 Filed Jul 2, 2020 20:56 UTC	ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278	GrantPhantom Stock Units · Derivative	232.303	$0.00 Strike: $118.38	$0.00	Disclosure SEC source: 0000911916-20-000162 · edgar.xml · derivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,682.789 Underlying: Common Stock · 232.303 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: 116.152 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: 116.152 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. Read SEC document
May 13, 2020 Filed May 15, 2020 20:47 UTC	PPD, Inc. PPD · Entity 15247	GrantCommon stock	3,728	$0.00	$0.00	Disclosure SEC source: 0000899243-20-013234 · doc4.xml · nonDerivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,199 F1 · kind: Represents a grant of restricted stock units which will vest on the earlier of the one-year anniversary of the grant date and the date of the next regularly scheduled annual meeting of stockholders of the issuer, subject to continued service through the vesting date. Read SEC document
May 08, 2020 Filed May 12, 2020 20:36 UTC	ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278	GrantRestricted Stock Units · Derivative	1,077.229	$0.00	$0.00	Disclosure SEC source: 0000911916-20-000105 · edgar.xml · derivative · entry 2 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,155.351 Underlying: Common Stock · 1,077.229 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. Read SEC document
May 08, 2020 Filed May 12, 2020 20:36 UTC	ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278	GrantPhantom Stock Units · Derivative	500	$0.00 Strike: $120.68	$0.00	Disclosure SEC source: 0000911916-20-000105 · edgar.xml · derivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,450.486 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 3.322 phantom stock units accrued on April 30, 2020 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document
March 31, 2020 Filed Apr 1, 2020 20:30 UTC	CAMPBELL'S Co CPB · Entity 3700	GrantPhantom Stock · Derivative	1,286.4	$0.00	$0.00	Disclosure SEC source: 0000016732-20-000041 · wf-form4_158577298217276.xml · derivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,367.63 Underlying: Common Stock · 1,286.4 shares Expires not disclosed F1 · derivative.exercise_price: Each share of Phantom Stock is the economic equivalent of one share of issuer common stock. F2 · derivative.exercise_date: Phantom shares are fully vested. F3 · derivative.expiration_date: The value of phantom stock is payable in cash from the Company's Supplemental Retirement Plan upon reporting person's retirement, resignation or termination. F4 · balance_after: Includes 129.16 shares acquired through dividend reinvestment since the reporting person's last report. Read SEC document
March 31, 2020 Filed Apr 2, 2020 21:23 UTC	ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278	GrantPhantom Stock Units · Derivative	277.722	$0.00 Strike: $99.02	$0.00	Disclosure SEC source: 0000911916-20-000092 · edgar.xml · derivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,947.164 Underlying: Common Stock · 277.722 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: 138.861 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: 138.861 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 2.385 phantom stock units accrued on January 31, 2020 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document
February 28, 2020 Filed Mar 3, 2020 20:23 UTC	FULLER H B CO FUL · Entity 4255	GrantStock Units · Derivative	214.91	$39.23 Strike: $0.00	$8,430.92	Disclosure SEC source: 0001225208-20-004106 · doc4.xml · derivative · entry 2 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,971.87 Underlying: Common Stock · 214.91 shares Expires not disclosed F1 · derivative.exercise_price: These units convert into shares of common stock on a 1-for-1 basis. F2 · derivative.exercise_date: These units will be converted into shares of common stock upon retirement, death, disability or certain specified events, all as defined in such plan, subject to holding periods required by law. F2 · derivative.expiration_date: These units will be converted into shares of common stock upon retirement, death, disability or certain specified events, all as defined in such plan, subject to holding periods required by law. F3 · balance_after: This amount includes stock units acquired pursuant to a dividend equivalent feature of the Directors Deferred Compensation Plan. Read SEC document
February 10, 2020 Filed Feb 12, 2020 21:21 UTC	PPD, Inc. PPD · Entity 15247	PurchaseCommon stock	8,000	$27.00	$216,000.00	Disclosure SEC source: 0000899243-20-004257 · doc4.xml · nonDerivative · entry 3 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,471 F2 · price: Shares were acquired in a directed share program in connection with the Issuer's initial public offering. Read SEC document
February 10, 2020 Filed Feb 12, 2020 21:21 UTC	PPD, Inc. PPD · Entity 15247	GrantCommon stock	25,471	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-20-004257 · doc4.xml · nonDerivative · entry 2 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,471 F1 · price: Upon the completion of the initial public offering of PPD, Inc. (the "Issuer"), all shares of the Issuer's non-voting common stock automatically converted into shares of the Issuer's voting common stock on a one-for-one basis. Read SEC document
February 10, 2020 Filed Feb 12, 2020 21:21 UTC	PPD, Inc. PPD · Entity 15247	Disposition to issuerNon-voting common stock	25,471	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-20-004257 · doc4.xml · nonDerivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Upon the completion of the initial public offering of PPD, Inc. (the "Issuer"), all shares of the Issuer's non-voting common stock automatically converted into shares of the Issuer's voting common stock on a one-for-one basis. F1 · price: Upon the completion of the initial public offering of PPD, Inc. (the "Issuer"), all shares of the Issuer's non-voting common stock automatically converted into shares of the Issuer's voting common stock on a one-for-one basis. Read SEC document
December 31, 2019 Filed Jan 3, 2020 21:44 UTC	ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278	GrantPhantom Stock Units · Derivative	184.564	$0.00 Strike: $149.00	$0.00	Disclosure SEC source: 0000911916-20-000011 · edgar.xml · derivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,667.057 Underlying: Common Stock · 184.564 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: 92.282 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: 92.282 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 2.580 phantom stock units accrued on October 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document
November 30, 2019 Filed Dec 3, 2019 18:37 UTC	FULLER H B CO FUL · Entity 4255	GrantStock Units · Derivative	496.19	$49.88 Strike: $0.00	$24,749.96	Disclosure SEC source: 0001225208-19-015145 · doc4.xml · derivative · entry 2 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,675.92 Underlying: Common Stock · 496.19 shares Expires not disclosed F1 · derivative.exercise_price: These units convert into shares of common stock on a 1-for-1 basis. F2 · derivative.exercise_date: These units will be converted into shares of common stock upon retirement, death, disability or certain specified events, all as defined in such plan, subject to holding periods required by law. F2 · derivative.expiration_date: These units will be converted into shares of common stock upon retirement, death, disability or certain specified events, all as defined in such plan, subject to holding periods required by law. F3 · balance_after: This amount includes stock units acquired pursuant to a dividend equivalent feature of the Directors Deferred Compensation Plan. Read SEC document
September 30, 2019 Filed Oct 2, 2019 20:37 UTC	ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278	GrantPhantom Stock Units · Derivative	174.466	$0.00 Strike: $136.13	$0.00	Disclosure SEC source: 0000911916-19-000174 · edgar.xml · derivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,479.913 Underlying: Common Stock · 174.466 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: 87.233 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: 87.233 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 1.953 phantom stock units accrued on July 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document
August 31, 2019 Filed Sep 4, 2019 19:35 UTC	FULLER H B CO FUL · Entity 4255	GrantStock Units · Derivative	580.85	$42.61 Strike: $0.00	$24,750.02	Disclosure SEC source: 0001225208-19-012115 · doc4.xml · derivative · entry 2 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,100.7 Underlying: Common Stock · 580.85 shares Expires not disclosed F1 · derivative.exercise_price: These units convert into shares of common stock on a 1-for-1 basis. F2 · derivative.exercise_date: These units will be converted into shares of common stock upon retirement, death, disability or certain specified events, all as defined in such plan, subject to holding periods required by law. F2 · derivative.expiration_date: These units will be converted into shares of common stock upon retirement, death, disability or certain specified events, all as defined in such plan, subject to holding periods required by law. F3 · balance_after: This amount includes stock units acquired pursuant to a dividend equivalent feature of the Directors Deferred Compensation Plan. Read SEC document
July 16, 2019 Filed Jul 17, 2019 21:59 UTC	FULLER H B CO FUL · Entity 4255	GrantStock Units · Derivative	2,389.36	$48.13 Strike: $0.00	$114,999.90	Disclosure SEC source: 0001225208-19-010319 · doc4.xml · derivative · entry 2 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,434.94 Underlying: Common Stock · 2,389.36 shares Expires not disclosed F1 · derivative.exercise_price: These units convert into shares of common stock on a 1-for-1 basis. F2 · derivative.exercise_date: These units will be converted into shares of common stock upon retirement, death, disability or certain specified events, all as defined in such plan, subject to holding periods required by law. F2 · derivative.expiration_date: These units will be converted into shares of common stock upon retirement, death, disability or certain specified events, all as defined in such plan, subject to holding periods required by law. F3 · balance_after: This amount includes stock units acquired pursuant to a dividend equivalent feature of the Directors Deferred Compensation Plan. Read SEC document
June 30, 2019 Filed Jul 2, 2019 20:15 UTC	ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278	GrantPhantom Stock Units · Derivative	204.161	$0.00 Strike: $116.33	$0.00	Disclosure SEC source: 0000911916-19-000142 · edgar.xml · derivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,303.494 Underlying: Common Stock · 204.161 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: 102.081 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: 102.081 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. Read SEC document
May 31, 2019 Filed Jun 3, 2019 21:18 UTC	FULLER H B CO FUL · Entity 4255	GrantStock Units · Derivative	627.69	$39.43 Strike: $0.00	$24,749.82	Disclosure SEC source: 0001225208-19-008740 · doc4.xml · derivative · entry 2 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,045.58 Underlying: Common Stock · 627.69 shares Expires not disclosed F1 · derivative.exercise_price: These units convert into shares of common stock on a 1-for-1 basis. F2 · derivative.exercise_date: These units will be converted into shares of common stock upon retirement, death, disability or certain specified events, all as defined in such plan, subject to holding periods required by law. F2 · derivative.expiration_date: These units will be converted into shares of common stock upon retirement, death, disability or certain specified events, all as defined in such plan, subject to holding periods required by law. F3 · balance_after: This amount includes stock units acquired pursuant to a dividend equivalent feature of the Directors Deferred Compensation Plan. Read SEC document
May 10, 2019 Filed May 14, 2019 21:26 UTC	ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278	GrantRestricted Stock Units · Derivative	1,078.122	$0.00	$0.00	Disclosure SEC source: 0000911916-19-000115 · edgar.xml · derivative · entry 2 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,078.122 Underlying: Common Stock · 1,078.122 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. Read SEC document
May 10, 2019 Filed May 14, 2019 21:26 UTC	ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278	GrantPhantom Stock Units · Derivative	500	$0.00 Strike: $120.58	$0.00	Disclosure SEC source: 0000911916-19-000115 · edgar.xml · derivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,099.333 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 0.811 phantom stock units accrued on April 30, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document
March 31, 2019 Filed Apr 2, 2019 23:04 UTC	ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278	GrantPhantom Stock Units · Derivative	186.67	$0.00 Strike: $127.23	$0.00	Disclosure SEC source: 0000911916-19-000102 · edgar.xml · derivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 598.522 Underlying: Common Stock · 186.67 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: 93.335 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: 93.335 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes .401 phantom stock units accrued on January 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document
February 28, 2019 Filed Mar 1, 2019 21:23 UTC	FULLER H B CO FUL · Entity 4255	GrantStock Units · Derivative	490.29	$50.48 Strike: $0.00	$24,749.84	Disclosure SEC source: 0001225208-19-004145 · doc4.xml · derivative · entry 2 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,350 Underlying: Common Stock · 490.29 shares Expires not disclosed F1 · derivative.exercise_price: These units convert into shares of common stock on a 1-for-1 basis. F2 · derivative.exercise_date: These units will be converted into shares of common stock upon retirement, death, disability or certain specified events, all as defined in such plan, subject to holding periods required by law. F2 · derivative.expiration_date: These units will be converted into shares of common stock upon retirement, death, disability or certain specified events, all as defined in such plan, subject to holding periods required by law. F3 · balance_after: This amount includes stock units acquired pursuant to a dividend equivalent feature of the Directors Deferred Compensation Plan. Read SEC document
February 07, 2019 Filed Feb 8, 2019 21:34 UTC	ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278	PurchaseCommon Stock	1,650	$118.18	$194,990.24	Disclosure SEC source: 0000911916-19-000028 · edgar.xml · nonDerivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,650 Read SEC document
January 08, 2019 Filed Jan 9, 2019 22:02 UTC	CAMPBELL'S Co CPB · Entity 3700	GrantPhantom Stock · Derivative	3,952.07	$0.00	$0.00	Disclosure SEC source: 0000016732-19-000002 · wf-form4_154707134104352.xml · derivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,952.07 Underlying: Common Stock · 3,952.07 shares Expires not disclosed F1 · derivative.exercise_price: Each share of Phantom Stock is the economic equivalent of one share of issuer common stock. F2 · derivative.exercise_date: Phantom shares are fully vested. F3 · derivative.expiration_date: The value of phantom stock is payable in cash from the Company's Supplemental Retirement Plan upon reporting person's retirement, resignation or termination. Read SEC document
December 31, 2018 Filed Jan 3, 2019 21:19 UTC	ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278	GrantPhantom Stock Units · Derivative	229.668	$0.00 Strike: $103.41	$0.00	Disclosure SEC source: 0000911916-19-000007 · edgar.xml · derivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 411.451 Underlying: Common Stock · 229.668 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: 114.834 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: 114.834 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. Read SEC document
November 30, 2018 Filed Dec 4, 2018 13:22 UTC	FULLER H B CO FUL · Entity 4255	GrantStock Units · Derivative	513.06	$48.24 Strike: $0.00	$24,750.01	Disclosure SEC source: 0001225208-18-016109 · doc4.xml · derivative · entry 2 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,799.33 Underlying: Common Stock · 513.06 shares Expires not disclosed F1 · derivative.exercise_price: These units convert into shares of common stock on a 1-for-1 basis. F2 · derivative.exercise_date: These units will be converted into shares of common stock upon retirement, death, disability or certain specified events, all as defined in such plan, subject to holding periods required by law. F2 · derivative.expiration_date: These units will be converted into shares of common stock upon retirement, death, disability or certain specified events, all as defined in such plan, subject to holding periods required by law. F3 · balance_after: This amount includes stock units acquired pursuant to a dividend equivalent feature of the Directors Deferred Compensation Plan. Read SEC document
September 30, 2018 Filed Oct 2, 2018 20:01 UTC	ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278	GrantPhantom Stock Units · Derivative	181.783	$0.00 Strike: $130.65	$0.00	Disclosure SEC source: 0000911916-18-000181 · edgar.xml · derivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181.783 Underlying: Common Stock · 181.783 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: 90.892 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: 90.892 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. Read SEC document
August 31, 2018 Filed Sep 4, 2018 20:27 UTC	FULLER H B CO FUL · Entity 4255	GrantStock Units · Derivative	434.29	$56.99 Strike: $0.00	$24,750.19	Disclosure SEC source: 0001225208-18-013056 · doc4.xml · derivative · entry 2 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,222.35 Underlying: Common Stock · 434.29 shares Expires not disclosed F1 · derivative.exercise_price: These units convert into shares of common stock on a 1-for-1 basis. F2 · derivative.exercise_date: These units will be converted into shares of common stock upon retirement, death, disability or certain specified events, all as defined in such plan, subject to holding periods required by law. F2 · derivative.expiration_date: These units will be converted into shares of common stock upon retirement, death, disability or certain specified events, all as defined in such plan, subject to holding periods required by law. F3 · balance_after: This amount includes stock units acquired pursuant to a dividend equivalent feature of the Directors Deferred Compensation Plan. Read SEC document
July 12, 2018 Filed Jul 16, 2018 16:14 UTC	FULLER H B CO FUL · Entity 4255	GrantStock Units · Derivative	2,048.45	$56.14 Strike: $0.00	$114,999.98	Disclosure SEC source: 0001225208-18-011670 · doc4.xml · derivative · entry 2 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,737.76 Underlying: Common Stock · 2,048.45 shares Expires not disclosed F1 · derivative.exercise_price: These units convert into shares of common stock on a 1-for-1 basis. F2 · derivative.exercise_date: These units will be converted into shares of common stock upon retirement, death, disability or certain specified events, all as defined in such plan, subject to holding periods required by law. F2 · derivative.expiration_date: These units will be converted into shares of common stock upon retirement, death, disability or certain specified events, all as defined in such plan, subject to holding periods required by law. F3 · balance_after: This amount includes stock units acquired pursuant to a dividend equivalent feature of the Directors Deferred Compensation Plan. Read SEC document
June 06, 2018 Filed Jun 7, 2018 19:53 UTC	CAMPBELL'S Co CPB · Entity 3700	PurchaseCommon Stock	2,000	$33.22	$66,431.20	Disclosure SEC source: 0000016732-18-000051 · wf-form4_152840120018058.xml · nonDerivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,330 Read SEC document
May 31, 2018 Filed Jun 4, 2018 16:51 UTC	FULLER H B CO FUL · Entity 4255	GrantStock Units · Derivative	480.12	$51.55 Strike: $0.00	$24,750.19	Disclosure SEC source: 0001225208-18-010089 · doc4.xml · derivative · entry 2 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,689.31 Underlying: Common Stock · 480.12 shares Expires not disclosed F1 · derivative.exercise_price: These units convert into shares of common stock on a 1-for-1 basis. F2 · derivative.exercise_date: These units will be converted into shares of common stock upon retirement, death, disability or certain specified events, all as defined in such plan, subject to holding periods required by law. F2 · derivative.expiration_date: These units will be converted into shares of common stock upon retirement, death, disability or certain specified events, all as defined in such plan, subject to holding periods required by law. F3 · balance_after: This amount includes stock units acquired pursuant to a dividend equivalent feature of the Directors Deferred Compensation Plan. Read SEC document
April 03, 2018 Filed Apr 4, 2018 20:38 UTC	CAMPBELL'S Co CPB · Entity 3700	GrantCommon Stock	2,330	$0.00	$0.00	Disclosure SEC source: 0000016732-18-000034 · wf-form4_152287427562919.xml · nonDerivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,330 Read SEC document
April 03, 2018 Filed Apr 5, 2018 18:56 UTC	Allergan plc AGN · Entity 149298	Tax withholdingOrdinary Shares, par value $0.0001	619	$164.74	$101,974.06	Disclosure SEC source: 0000903423-18-000198 · hilladof4.xml · nonDerivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,911 F1 · balance_after: Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc. Read SEC document
March 15, 2018 Filed Mar 19, 2018 09:36 UTC	Allergan plc AGN · Entity 149298	PurchaseOrdinary Shares, par value $0.0001	895	$167.39	$149,814.05	Disclosure SEC source: 0001179110-18-004521 · edgar.xml · nonDerivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,530 F1 · balance_after: Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.